If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
675.00    -14.00 (-2.03%)
Bid:
670.00
Ask:
680.00
Spread: 10.00 (1.493%)
Market Cap: £237.86m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
17th Jul 20194:38 pmRNSResult of AGM
17th Jul 20192:41 pmRNSPurchase of own shares
16th Jul 20194:29 pmRNSPurchase in own shares
15th Jul 20197:00 amRNSInvestment
12th Jul 201911:44 amRNSPurchase of own shares
10th Jul 20193:58 pmRNSPDMR and Director Dealings
10th Jul 20193:55 pmRNSPDMR and Director Dealings
9th Jul 20198:43 amRNSPDMR and Director Dealings
8th Jul 20192:55 pmRNSPDMR and Director Dealings
26th Jun 20193:44 pmRNSPDMR and Director Dealings
24th Jun 20194:56 pmRNSPDMR and Director Dealings
24th Jun 20194:55 pmRNSNotice of AGM
24th Jun 20194:52 pmRNSPDMR and Director Dealings
18th Jun 201910:31 amRNSShare Incentive Plan - Replacement RNS
17th Jun 20192:20 pmRNSShare Incentive Plan
13th Jun 20195:05 pmRNSDividend Declaration
13th Jun 20193:52 pmRNSStatement re PDMR/PCA Dealing
11th Jun 20197:00 amRNSFinal Results
1st May 20197:00 amRNSDirectorate Change
16th Apr 20196:11 pmRNSSignificant Shareholding
15th Apr 201910:21 amRNSForm 8.3 - B.P Marsh & Partners PLC
4th Apr 20195:49 pmRNSDirector/PDMR Shareholding
4th Apr 20195:47 pmRNSDirector/PDMR Shareholding
4th Apr 20195:43 pmRNSDirector/PDMR Shareholding
1st Apr 20196:25 pmRNSDirector/PDMR Shareholding
1st Apr 20194:44 pmRNSInvestee Co. Update - Nexus Underwriting Mgt Ltd
20th Mar 20199:53 amRNSTransaction in Own Shares
19th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20194:41 pmRNSTransaction in Own Shares
13th Mar 20193:55 pmRNSTransaction in Own Shares
12th Mar 20192:34 pmRNSShare Buy-Back Policy Update
11th Mar 20194:54 pmRNSTransaction in Own Shares
7th Mar 20195:53 pmRNSTransaction in Own Shares
6th Mar 20195:22 pmRNSTransaction in Own Shares
5th Mar 20196:10 pmRNSDirector/PDMR Shareholding
5th Mar 20196:07 pmRNSTransaction in Own Shares
28th Feb 20195:50 pmRNSDirector/PDMR Shareholding
26th Feb 20194:51 pmRNSDirector/PDMR Shareholding
25th Feb 20196:26 pmRNSTransaction in Own Shares
21st Feb 20193:47 pmRNSTransaction in Own Shares
19th Feb 20191:09 pmRNSDirector/PDMR Shareholding
18th Feb 20194:28 pmRNSTransaction in Own Shares
8th Feb 20193:11 pmRNSDirector/PDMR Shareholding
7th Feb 20197:00 amRNSTrading Update
4th Feb 20193:45 pmRNSDirector/PDMR Shareholding
22nd Jan 20193:30 pmRNSTransaction in Own Shares
18th Jan 201911:49 amRNSInvestee Company Update - XPT Group LLC
17th Jan 20191:31 pmRNSTransaction in Own Shares
17th Jan 20191:26 pmRNSDirector/PDMR Shareholding
21st Dec 20188:22 amRNSInvestee Company Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.